PARAMOUNT: Descriptive subgroup analyses of final overall survival for the phase iii study of maintenance pemetrexed versus placebo following induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer

1. Reck, M.
2. Paz-Ares, L.G.
3. De Marinis, F.
4. Molinier, O.
5. Sahoo, T.P.
6. Laack, E.
7. John, W.
8. Zimmermann, A.H.
9. Visseren-Grul, C.
10. Gridelli, C.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1097/JTO.0000000000000076 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus